Skip to main content
. 2006 Jun;44(6):1977–1981. doi: 10.1128/JCM.00029-06

TABLE 5.

In vitro activity of amphotericin B, fluconazole, and flucytosine against Norwegian candidemia isolates

Species Antifungal agent (no. of isolates) MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml)
C. albicans Amphotericin B (934) 0.06-2 0.5 1
Fluconazole (934) 0.25-4 0.5 1
Flucytosine (734) 0.06-64 0.125 0.5
C. glabrata Amphotericin B (180) 0.06-2 0.5 1
Fluconazole (180) 1-64 16 64
Flucytosine (138) 0.06-32 0.125 0.25
C. tropicalis Amphotericin B (93) 0.06-1 0.5 1
Fluconazole (93) 0.5-64 1 4
Flucytosine (81) 0.06-64 0.125 0.5
C. parapsilosis Amphotericin B (82) 0.06-1 0.5 1
Fluconazole (82) 0.25-16 1 2
Flucytosine (69) 0.125-1 0.125 0.25
C. krusei Amphotericin B (22) 0.25-2 1 2
Fluconazole (22) 32-64 64 64
Flucytosine (17) 16-32 16 32
Othera Amphotericin B (37) 0.06-1 0.5 1
Fluconazole (37) 0.25-64 0.5 64
Flucytosine (26) 0.06-64 0.25 16
All isolates Amphotericin B (1,348) 0.06-2 0.5 1
Fluconazole (1,348) 0.25-64 0.5 16
Flucytosine (1,065) 0.06-64 0.125 0.5
a

Other species include C. blankii, C. dubliniensis, C. guilliermondii, C. kefyr, C. lusitaniae, C. norvegensis, C. sake, and C. sphaerica.